Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 74426 - 74450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sirolimus	Approved Investigational	HMGCR	3156	upregulated	Sirolimus results in increased expression of HMGCR mRNA	5q13.3	A21638
Sirolimus	Approved Investigational	HSPA1B	3304	downregulated	Sirolimus results in decreased expression of HSPA1B mRNA	6p21.33	A20727
Sirolimus	Approved Investigational	HSPA5	3309	downregulated	Sirolimus results in decreased expression of HSPA5 mRNA	9q33.3	A20727
Sirolimus	Approved Investigational	ID1	3397	upregulated	Sirolimus results in increased expression of ID1 mRNA	20q11.21	A20795 A20727
Sirolimus	Approved Investigational	IL10	3586	downregulated	Sirolimus results in decreased expression of IL10 mRNA	1q32.1	A24293
Sirolimus	Approved Investigational	KLF2	10365	upregulated	Sirolimus results in increased expression of KLF2 mRNA	19p13.11	A20727
Sirolimus	Approved Investigational	KLHL24	54800	upregulated	Sirolimus results in increased expression of KLHL24 mRNA	3q27.1	A20727
Sirolimus	Approved Investigational	MAP1LC3B	81631	upregulated	Sirolimus results in increased expression of MAP1LC3B mRNA	16q24.2	A23565
Sirolimus	Approved Investigational	MMP1	4312	upregulated	Sirolimus results in increased expression of MMP1 mRNA	11q22.2	A24294
Sirolimus	Approved Investigational	MSR1	4481	downregulated	Sirolimus results in decreased expression of MSR1 mRNA	8p22	A24290
Sirolimus	Approved Investigational	MTOR	2475	downregulated	Sirolimus results in decreased expression of MTOR mRNA	1p36.22	A24295
Sirolimus	Approved Investigational	NOS3	4846	downregulated	Sirolimus results in decreased expression of NOS3 mRNA	7q36.1	A23565
Sirolimus	Approved Investigational	PDCD4	27250	upregulated	Sirolimus results in increased expression of PDCD4 mRNA	10q25.2	A20397 A20727
Sirolimus	Approved Investigational	PLCL1	5334	upregulated	Sirolimus results in increased expression of PLCL1 mRNA	2q33.1	A20727
Sirolimus	Approved Investigational	PNRC1	10957	upregulated	Sirolimus results in increased expression of PNRC1 mRNA	6q15	A20727
Sirolimus	Approved Investigational	PSMD11	5717	downregulated	Sirolimus results in decreased expression of PSMD11 mRNA	17q11.2	A24296
Sirolimus	Approved Investigational	S1PR1	1901	upregulated	Sirolimus results in increased expression of S1PR1 mRNA	1p21.2	A20727
Sirolimus	Approved Investigational	SCARB2	950	downregulated	Sirolimus results in decreased expression of SCARB2 mRNA	4q21.1	A24290
Sirolimus	Approved Investigational	SHISA2	387914	upregulated	Sirolimus results in increased expression of SHISA2 mRNA	13q12.13	A20727
Sirolimus	Approved Investigational	TERT	7015	downregulated	Sirolimus results in decreased expression of TERT mRNA	5p15.33	A24297 A24298 A24299
Sirolimus	Approved Investigational	TIMP3	7078	downregulated	Sirolimus results in decreased expression of TIMP3 mRNA	22q12.3	A24294
Sirolimus	Approved Investigational	TYMS	7298	downregulated	Sirolimus results in decreased expression of TYMS mRNA	18p11.32	A22649
Sirolimus	Approved Investigational	VEGFA	7422	downregulated	Sirolimus results in decreased expression of VEGFA mRNA	6p21.1	A20398
Sirolimus	Approved Investigational	WT1	7490	downregulated	Sirolimus results in decreased expression of WT1 mRNA	11p13	A24300
Sirolimus	Approved Investigational	ZBED8	63920	upregulated	Sirolimus results in increased expression of ZBED8 mRNA	5q33.3	A20727

Displaying entries 74426 - 74450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability